The current PE ratio of ARRY can't be determined, as the TTM EPS of -$0.94 is negative. The most recent PE ratio recorded for Array Technologies was 68.4 in June 2024.
Over the last four years, the average PE ratio of Array Technologies has been 84.65. In the past four years, ARRY's PE ratio was at its highest in the Mar 2023 quarter at 273.5, with a price of $21.88 and an EPS of $0.08. The Dec 2023 quarter recorded the bottom point at 29.47, with a price of $16.8 and an EPS of $0.57.
Year | PE ratio | Change |
---|---|---|
2023 | 29.47 | N/A |
2022 | N/A | N/A |
2021 | N/A | N/A |
2020 | 88.04 | N/A |
2019 | N/A | N/A |
2018 | N/A | N/A |
Stock name | PE ratio | Market cap |
---|---|---|
NVS Novartis AG | 11.4 | $196.73B |
AZN Astrazeneca plc | 31.83 | $206.21B |
AMGN Amgen Inc | 33.36 | $141.47B |
LLY ELI LILLY & Co | 85.48 | $753.89B |
ARRY Array Technologies Inc | N/A | $897.98M |
The current price to earnings ratio of ARRY can't be calculated, as its EPS of -$0.94 is negative.
Over the last 3 years, the average price to earnings ratio for ARRY stock is 84.08.
In the last four years, the Mar 2023 quarter recorded the highest quarterly PE ratio at 273.5.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.